NCT04619056View on ClinicalTrials.gov

First-in-man Clinical Trial of CEB-01 PLGA Membrane in Recurrent or Locally Advanced Retroperitoneal Soft Tissue Sarcoma

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

June 3, 2020

Primary Completion Date

May 15, 2025

Study Completion Date

May 15, 2025

Conditions
Locally Advanced Soft Tissue SarcomaRecurrent Soft Tissue Sarcoma
Interventions
DRUG

CEB-01 membrane loaded with SN-38

CEB-01 is a polymeric drug with a delivery system loaded with SN-38, and will be placed in the surgical bed at the time of tumor resection.

Trial Locations (5)

28007

Hospital General Universitario Gregorio Marañón, Madrid

28040

Fundación Jiménez Díaz, Madrid

46026

Hospital Universitario y Politécnico La Fe, Valencia

08041

Hospital de la Santa Creu i Sant Pau, Barcelona

08035

Hospital Universitario Vall d'Hebron, Barcelona

Sponsors

Lead Sponsor

CEBIOTEX
All Listed Sponsors
lead

CEBIOTEX

INDUSTRY